Patents by Inventor Denis Martin

Denis Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050107597
    Abstract: The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 19, 2005
    Inventors: Nathalie Charland, Josee Hamel, Bernard Brodeur, Denis Martin, Isabelle Charlebois, Diane Bussiere
  • Publication number: 20050080233
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamella) catarrhalis which may be useful for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: June 18, 2002
    Publication date: April 14, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Genevieve Leblanc, Julie Couture
  • Publication number: 20050070691
    Abstract: The present invention relates to polypeptides, more particularly polypeptides of Moraxella (Branhamella) catarrhalis which may be used to prevent, diagnose and/or treat Moraxella (Branhamella) catarrhalis infection.
    Type: Application
    Filed: November 15, 2002
    Publication date: March 31, 2005
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Publication number: 20040242859
    Abstract: The present invention relates to polypeptides of Moraxella (Branhamela) catarrhalis wich may be used for prophy-laxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: February 26, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Julie Couture
  • Publication number: 20040242844
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: July 16, 2004
    Publication date: December 2, 2004
    Inventors: Denis Martin, Stephane Rioux, Bernard Brodeur, Josee Hamel, Martine Boyer
  • Publication number: 20040236087
    Abstract: The present invention relates to polypeptides of Moraxella(Branhamella) calarrhalis which may be useful for prophylaxis, diagnosis and/or therapy purposes.
    Type: Application
    Filed: June 2, 2004
    Publication date: November 25, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R. Brodeur, Stephane Rioux, Julie Couture
  • Publication number: 20040171802
    Abstract: The present invention relates to polypeptides of Haemophilus influenzae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: April 2, 2003
    Publication date: September 2, 2004
    Inventors: Josee Hamel, France Couture, Bernard R. Brodeur, Denis Martin, Catherine Quellet, Mireille Tremblay, Annie Charbonneau, Catherine Vayssier
  • Publication number: 20040171113
    Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.
    Type: Application
    Filed: April 19, 2004
    Publication date: September 2, 2004
    Inventors: Denis Martin, Josee Hamel, Bernard R Brodeur, Stephane Rioux, Martine Boyer
  • Publication number: 20040132652
    Abstract: Pharmaceutical compositions comprising a liposome associated to N. meningitidis polypeptides fragments or analogs thereof or corresponding DNA fragments, can be used to prevent, diagnose and/or treat neisserial infections.
    Type: Application
    Filed: August 28, 2003
    Publication date: July 8, 2004
    Applicant: Shire BioChem Inc.
    Inventors: Denis Martin, Stephane Rioux
  • Publication number: 20040119625
    Abstract: A multi-channel integrated circuit comprises a plurality of channels (CH1 to CH20). A DAC (3) is provided in each channel (CH1 to CH20) for converting digital data inputted to the circuit (1) through an I/O port (14). Digital data to be converted by the DACs (3) is selectively applied to input registers (10) of each channel (CH1 to CH20) on a digital data bus (16) under the control of an interface and control logic circuit (15). The digital words written to the input registers (10) are in turn written to DAC registers (9) through corresponding digital switches (12) for conversion by the DACs (3). A clear code register (22) stores a clear code for writing to the DAC registers (9) in response to a clear signal applied to a clear terminal (24) of the circuit (1) so that analogue outputs appearing on output terminals (5) of the channels (CH1 to CH20) are of a predetermined value, typically, zero volts, when the circuit (1) is set in a clear condition.
    Type: Application
    Filed: December 9, 2003
    Publication date: June 24, 2004
    Inventors: Donal P. Geraghty, Denis Martin O'Connor, Dennis Arnold Dempsey
  • Publication number: 20040097706
    Abstract: The present invention relates to antigens, more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: November 18, 2003
    Publication date: May 20, 2004
    Inventors: Denis Martin, Bernard Brodeur, Josee Hamel, Stephane Rioux, Patrick Rheault
  • Publication number: 20040071730
    Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.
    Type: Application
    Filed: September 26, 2003
    Publication date: April 15, 2004
    Inventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee HAmel, Bernard Brodeur
  • Publication number: 20030232976
    Abstract: The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 18, 2003
    Inventors: Josee Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe
  • Publication number: 20030228323
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: January 13, 2003
    Publication date: December 11, 2003
    Inventors: Bernard R. Brodeur, Clement Rioux, Martine Boyer, Isabelle Charlebois, Josee Hamel, Denis Martin
  • Publication number: 20030225161
    Abstract: A compound of the formula 1
    Type: Application
    Filed: April 28, 2003
    Publication date: December 4, 2003
    Inventors: Richard B. Silverman, Ryszard Andruszkiewicz, Po-Wai Yuen, Denis Martin Sobieray, Lloyd Charles Franklin, Mark Alan Schwindt
  • Publication number: 20030165528
    Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
    Type: Application
    Filed: April 22, 2003
    Publication date: September 4, 2003
    Inventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
  • Patent number: 6615380
    Abstract: According to the present invention, during scan conversion, non-scan memory cells of a circuit design are replaced with scan cells to form a scan chain. The scan chain is transformed by the test synthesis tool of the present invention into dynamic scan chains with the addition of reconfiguration circuitry. The reconfiguration circuitry partitions the scan chain into multiple segments and enables each segment to be selectively “bypassed” (or deactivated) during test application. Shorter test patterns that are only pertinent to one or more segments are necessary, resulting in a reduction in overall test data volume and test application time. The present invention also provides a modified ATPG technique for generating test patterns for the dynamic scan chains.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: September 2, 2003
    Assignee: Synopsys Inc.
    Inventors: Rohit Kapur, Denis Martin, Thomas W. Williams
  • Publication number: 20030077293
    Abstract: Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: June 20, 2001
    Publication date: April 24, 2003
    Inventors: Josee Hamel, Catherine Ouellet, Nathalie Charland, Denis Martin, Bernard Brodeur
  • Publication number: 20030059896
    Abstract: Chlamydia pneumoniae polypeptides and polynucleotides encoding them are disclosed. Said polypeptides are antigenic and therefore useful components for the prophylaxis, diagnosis or therapy of Chlamydial infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting Chlamydia bacterial infection, particularly C. pneumoniae.
    Type: Application
    Filed: December 20, 2001
    Publication date: March 27, 2003
    Applicant: Shire BioChem Inc.
    Inventors: France Couture, Josee Hamel, Bernard R. Brodeur, Denis Martin, Pascal Brassard, Frederic Beaudoin, Paul Prefontaine
  • Patent number: 6539536
    Abstract: A computer implemented process and system for electronic design automation (EDA) using groups of multiple cells having loop-back connections for modeling port electrical characteristics. Multi-bit cells have multiple gates of the same function implemented within a same cell. Multi-bit components have multiple multi-bit cells implemented within a same component. Scannable multi-bit cells and components are similar to multi-bit cells and components but contain scannable sequential elements with scan chains installed. Multi-bit cells may or may not have each sequential cells' input and each sequential cells' output available externally. The scannable sequential elements of a multi-bit component are ordered into a predefined scan chain which is defined by the library containing the multi-bit component or multi-bit cell. During scan replacement processes of the EDA compile process, multi-bit cells and components of the netlist are replaced with scannable multi-bit cells and components.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: March 25, 2003
    Assignee: Synopsys, Inc.
    Inventors: Harbinder Singh, Denis Martin, Srinivas Ajjarapu, Robert Walker